Pittsburgh, PA, United States of America

Leila Terrab

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Pittsburgh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leila Terrab. Retrieved from https://idiyas.com/inventor/leila-terrab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leila Terrab: Inventor in Therapeutic Research.

Introduction

Leila Terrab is an inventor associated with Pittsburgh, Pennsylvania, and the University of Pittsburgh. Her patent work concerns compounds that may have applications in treating disorders involving heat-shock proteins and protein aggregation.

Latest Patents

The supplied information lists one patent for Terrab: “Heat shock protein modulators and anti-Huntington disease therapeutic agents.” The patent describes thiadiazine compounds, derivatives, and compositions that may be used to treat or prevent heat-shock protein-responsive disorders or suppress protein aggregation. It also identifies potential applications in cancer, neurodegenerative disorders, and other heat-shock protein-responsive conditions. The supplied patent count is 1 patent.

Career Highlights

Terrab’s listed patent connects her work with therapeutic research at the University of Pittsburgh. Its described compounds and compositions are directed toward potential treatment strategies for Huntington disease and other conditions associated with heat-shock proteins or protein aggregation.

Collaborations

The supplied information names Peter Wipf and Linh Khai Ngo as Terrab’s coworkers. Their names are associated here with her University of Pittsburgh research context.

Conclusion

Leila Terrab’s listed invention focuses on thiadiazine-based compounds with potential applications in Huntington disease research and other therapeutic areas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…